Robert A. Nagourney, MD

Robert A. Nagourney, MD is a medical oncologist and hematologist associated with Rational Therapeutics and the Nagourney Cancer Institute. In Outliving Cancer, he presents a personalized cancer-treatment model built around functional tumor profiling and the EVA-PCD assay, which measures programmed cell death in fresh tumor samples to help guide chemotherapy and targeted therapy selection.

The book biography describes him as board certified in internal medicine, medical oncology, and hematology, with undergraduate training in chemistry at Boston University, medical training at McGill University, internal medicine residency at the University of California, Irvine, and fellowship training in medical oncology at Georgetown University and hematology at The Scripps Research Institute.